Stakeholders in non-Vitamin K antagonist oral anticoagulants prescription: the case of Italy

被引：2
作者：
De Sensi, Francesco [1 ]
Paneni, Francesco [2 ]
机构：
[1] Misericordia Hosp, Dept Cardiol, Electrophysiol Unit, Via Senese 161, I-58100 Grosseto, Italy
[2] Karolinska Univ Hosp, Cardiol Unit, Stockholm, Sweden
来源：
EUROPACE | 2016年 / 18卷 / 05期
关键词：
ATRIAL-FIBRILLATION; WARFARIN;
D O I：
10.1093/europace/euv400
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：788 / 788
页数：1
相关论文
共 3 条
[1]   Factors Affecting Quality of Anticoagulation Control Among Patients With Atrial Fibrillation on Warfarin The SAMe-TT2R2 Score [J].
Apostolakis, Stavros ;
Sullivan, Renee M. ;
Olshansky, Brian ;
Lip, Gregory Y. H. .
CHEST, 2013, 144 (05) :1555-1563
[2]   Non-vitamin K antagonist oral anticoagulants and atrial fibrillation guidelines in practice: barriers to and strategies for optimal implementation [J].
Camm, A. John ;
Pinto, Fausto J. ;
Hankey, Graeme J. ;
Andreotti, Felicita ;
Hobbs, F. D. Richard .
EUROPACE, 2015, 17 (07) :1007-1017
[3]   Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin for Stroke Prevention in Non-Valvular Atrial Fibrillation: A Cost-Effectiveness Analysis [J].
Rognoni, Carla ;
Marchetti, Monia ;
Quaglini, Silvana ;
Liberato, Nicola Lucio .
CLINICAL DRUG INVESTIGATION, 2014, 34 (01) :9-17
1